NCT05878119: An ongoing trial by Metro International Biotech, LLC
This trial is ongoing. It must report results 4 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05878119 |
|---|---|
| Title | Effects of MIB-626 (β-Nicotinamide Mononucleotide) With and Without A High-Intensity Multi-Dimensional Exercise Training Program on Physical Performance, Muscle Bioenergetics, and Neuropsychological Performance in Highly Fit Young Adults |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 25, 2023 |
| Completion date | April 30, 2025 |
| Required reporting date | April 30, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |